March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...
CHICAGO, IL—A quality-improvement program from the Heart Rhythm Society was associated with improvements in care for patients early after they received a diagnosis of atrial fibrillation (AF), ...
A sub-study analysis of the EAST—AFNET 4 trial revealed how genetic risk for atrial fibrillation (AF) and stroke interacts with early rhythm control therapy: Early rhythm control reduces ...
In trial participants with mild to moderate CKD and recent atrial fibrillation, antiarrhythmic drugs did not increase the risk for heart failure hospitalization, death, or stroke compared with heart ...
Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial ...
The US atrial fibrillation (AF) guideline has received its first full update in nearly a decade, providing a new staging system, an emphasis on early rhythm control, and upgraded recommendations for ...
Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease. Is rhythm control underused in ATTR-CM? Drs ...
Please provide your email address to receive an email when new articles are posted on . A quality improvement initiative raised the proportion of patients with atrial fibrillation who received an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results